The reason the who should avoid list is framed so broadly is not boilerplate caution
Peripherally, these agents induce significant weight loss, enhance insulin sensitivity, and reduce hepatic de novo lipogenesis
The standard dosing regimen begins with 3 mg once daily for one month, increasing to 7 mg daily, with a possible further increase to 14 mg daily if additional glycaemic control is needed
One group of studies, called the STEP trials , focused on people who were overweight or obese but did not have diabetes
Individuals need to consult with their healthcare provider and consider all the possible side effects before starting any treatment
Diabetes, obesity & metabolism, 23(9), 20582066